In the Media | July 10, 2015

Canadian study to use two cancer-fighting viruses in world first

Cancer Topic:

Immunotherapy

Project Name:

Canadian Oncolytic Virus Consortium (COVCo)

Location:

Ontario

Related News & Events

Research Highlight|December 14, 2023

Study finds new clinical trial drug boosts ability of oncolytic virus to target and kill cancer

Researchers at The Ottawa Hospital have identified a method to boost the activity of cancer-fighting viruses by pairing one with a new cancer drug cur...

Research Highlight|December 14, 2020

Administering low-dose chemotherapy improves cancer vaccine’s effectiveness in mice models

TFRI-funded researchers from the Canadian Oncolytic Virus Consortium (COVCo) have found a way to improve the efficacy of therapeutic cancer vaccines, ...

Research Highlight|May 14, 2019

TFRI-funded scientists publish snapshot on oncolytic viruses in top scientific journal

Members of a long-standing TFRI team focused on developing cancer-killing viruses have published a snapshot article summarizing this promising area of...

Research Highlight|February 25, 2019

Blocking Type 1 Interferon reduces negative side-effects associated with potent immunotherapy

A group of scientists from the TFRI-funded Canadian Oncolytic Virus Consortium (COVCo) has discovered a new way to reduce negative side-effects associ...

Research Highlight|January 15, 2019

Use of mTOR inhibitors increases efficacy of herpes virus as an oncolytic therapy

A new study by a team of TFRI-funded scientists has found that combining a particular strain of the herpes virus with mTOR inhibitors improves viral r...

Research Highlight|September 10, 2018

Scientists use protein found in mosquito virus to suppress RNAi pathway, opening door to make oncolytic viruses more effective

By using a protein from a virus first found in Japanese mosquitoes in the 1950s, TFRI-funded researchers have discovered a new way to bypass antiviral...

Research Highlight|May 17, 2018

Erectile dysfunction drugs and flu vaccine may work together to help immune system fight cancer after surgery, study finds

A new study led by Dr. Rebecca Auer, a member of TFRI's Oncolytic Virus project and former recipient of a TFRI New Investigator Award, suggests that a...

Research Highlight|February 15, 2018

Vanadium compounds enhance efficacy of oncolytic viruses when used in combination therapy

A new class of compounds is generating excitement for its ability to enhance the efficacy of oncolytic viruses (OVs) and to stimulate the immune respo...

Research Highlight|January 03, 2018

New study shows viruses and checkpoint inhibitors work together to cure resistant breast cancer in mice

A new study led by TFRI-funded researchers at The Ottawa Hospital (TOH) and the University of Ottawa suggests that a combination of two immunotherapie...

All News & Events

Canadian study to use two cancer-fighting viruses in world first

John Bell

Funding Opportunities

Our Research

Impact

About Cancer

Updates

About Us

Contact